These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 19909356

  • 1. Inhibitory ITAMs as novel regulators of immunity.
    Blank U, Launay P, Benhamou M, Monteiro RC.
    Immunol Rev; 2009 Nov; 232(1):59-71. PubMed ID: 19909356
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory ITAM signaling traps activating receptors with the phosphatase SHP-1 to form polarized "inhibisome" clusters.
    Pfirsch-Maisonnas S, Aloulou M, Xu T, Claver J, Kanamaru Y, Tiwari M, Launay P, Monteiro RC, Blank U.
    Sci Signal; 2011 Apr 19; 4(169):ra24. PubMed ID: 21505186
    [Abstract] [Full Text] [Related]

  • 3. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr 19; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory ITAMs: a matter of life and death.
    Pinheiro da Silva F, Aloulou M, Benhamou M, Monteiro RC.
    Trends Immunol; 2008 Aug 19; 29(8):366-73. PubMed ID: 18602341
    [Abstract] [Full Text] [Related]

  • 5. How ITAMs inhibit signaling.
    Ivashkiv LB.
    Sci Signal; 2011 Apr 19; 4(169):pe20. PubMed ID: 21505184
    [Abstract] [Full Text] [Related]

  • 6. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM.
    Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, Ruffié C, Hénin D, Benhamou M, Pretolani M, Blank U, Monteiro RC.
    Immunity; 2005 Jan 19; 22(1):31-42. PubMed ID: 15664157
    [Abstract] [Full Text] [Related]

  • 7. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL, Blasioli J, Plas DR, Thomas ML, Yokoyama WM.
    J Immunol; 1999 Feb 01; 162(3):1318-23. PubMed ID: 9973385
    [Abstract] [Full Text] [Related]

  • 8. Fc receptors as determinants of allergic reactions.
    Kraft S, Novak N.
    Trends Immunol; 2006 Feb 01; 27(2):88-95. PubMed ID: 16324885
    [Abstract] [Full Text] [Related]

  • 9. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
    Daëron M, Jaeger S, Du Pasquier L, Vivier E.
    Immunol Rev; 2008 Aug 01; 224():11-43. PubMed ID: 18759918
    [Abstract] [Full Text] [Related]

  • 10. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P, Marchetti P, Fridman WH, Vivier E, Daëron M.
    J Immunol; 1999 Mar 15; 162(6):3168-75. PubMed ID: 10092767
    [Abstract] [Full Text] [Related]

  • 11. The many faces of ITAMs.
    Underhill DM, Goodridge HS.
    Trends Immunol; 2007 Feb 15; 28(2):66-73. PubMed ID: 17197236
    [Abstract] [Full Text] [Related]

  • 12. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov 15; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 13. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
    Peggs KS, Quezada SA, Allison JP.
    Immunol Rev; 2008 Aug 15; 224():141-65. PubMed ID: 18759925
    [Abstract] [Full Text] [Related]

  • 14. Reversal of Arthritis by Human Monomeric IgA Through the Receptor-Mediated SH2 Domain-Containing Phosphatase 1 Inhibitory Pathway.
    Rossato E, Ben Mkaddem S, Kanamaru Y, Hurtado-Nedelec M, Hayem G, Descatoire V, Vonarburg C, Miescher S, Zuercher AW, Monteiro RC.
    Arthritis Rheumatol; 2015 Jul 15; 67(7):1766-77. PubMed ID: 25833812
    [Abstract] [Full Text] [Related]

  • 15. The function of immunoglobulin A in immunity.
    Woof JM, Kerr MA.
    J Pathol; 2006 Jan 15; 208(2):270-82. PubMed ID: 16362985
    [Abstract] [Full Text] [Related]

  • 16. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13866-71. PubMed ID: 11698646
    [Abstract] [Full Text] [Related]

  • 17. IgA Fc receptor I is a molecular switch that determines IgA activating or inhibitory functions.
    Kanamaru Y, Blank U, Monteiro RC.
    Contrib Nephrol; 2007 Nov 20; 157():148-52. PubMed ID: 17495454
    [Abstract] [Full Text] [Related]

  • 18. Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling.
    Getahun A, Cambier JC.
    Immunol Rev; 2015 Nov 20; 268(1):66-73. PubMed ID: 26497513
    [Abstract] [Full Text] [Related]

  • 19. Asymmetrical phosphorylation and function of immunoreceptor tyrosine-based activation motif tyrosines in B cell antigen receptor signal transduction.
    Pao LI, Famiglietti SJ, Cambier JC.
    J Immunol; 1998 Apr 01; 160(7):3305-14. PubMed ID: 9531288
    [Abstract] [Full Text] [Related]

  • 20. Fc-receptors as regulators of immunity.
    Nimmerjahn F, Ravetch JV.
    Adv Immunol; 2007 Apr 01; 96():179-204. PubMed ID: 17981207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.